Abstract

Cytotoxicity, radiosensitivity, and hyperthermia sensitivity of hyaluronan-mediated dextran-coated super paramagnetic iron oxide nanoparticles (HA-DESPIONs) were assessed in CD44-expressing head and neck squamous cell carcinoma (HNSCC) cell lines at clinically relevant radiation dose and temperatures. Low-passage HNSCC cells were exposed to HA-DESPIONs and cytotoxicity was assessed using MTT assay. Radiosensitizing properties of graded doses of HA-DESPIONs were assessed in both unsorted and CD44-sorted cells using clonogenic assay in combination with 2 Gy exposure to X-rays. Hyperthermia-induced toxicity was measured at 40°C, 41°C, and 42°C using clonogenic assay. Cell death was assessed 24 hours after treatment using a flow cytometry-based apoptosis analysis. Results showed that HA-DESPIONs were nontoxic at moderate concentrations and did not directly radiosensitize the cell lines. Further, there was no significant difference in the radiosensitivity ofCD44highandCD44lowcells. However, HA-DESPIONs enhanced the effect of hyperthermia which resulted in reduced cell survival that appeared to be mediated through apoptosis. We demonstrated that HA-DESPIONs are nontoxic and although they do not enhance radiation sensitivity, they did increase the effect of local hyperthermia. These results support further development of drug-attached HA-DESPIONs in combination with radiation for targeting cancer stem cells (CSCs) and the development of an alternating magnetic field approach to activate the HA-DESPIONs attached to CSCs.

Highlights

  • Head and neck squamous cell carcinoma (HNSCC) is one of the leading cancers worldwide [1]

  • Previous work using the HA-DESPIONs has shown that they retained the native biological recognition of HA receptor CD44 [25]

  • In this study we examined the cytotoxic profile of HA-DESPIONs alone and in combination with radiation and hyperthermia and whether differential effects were evident based on CD44 expression levels

Read more

Summary

Introduction

Head and neck squamous cell carcinoma (HNSCC) is one of the leading cancers worldwide [1]. Heterogeneity can be attributed to clonal evolution, there is increasing awareness that cells have significantly different abilities to proliferate and form new tumors. This has led to the hypothesis that many cancer cells have a limited ability to divide and only a small subset of phenotypically distinct cells, the cancer stem cells (CSCs), have the capacity to self-renew and form new tumors [4]. Cancer stem cells (CSCs) arise from sequential mutations in normal stem cells due to progressive genetic instability and/or environmental factors

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call